Jaykay Enterprises Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Announcement under Regulation 30 of SEBI Listing Regulations - Press Release".
JAYKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jaykay Enterprises Limited reported strong Q3 FY2026 (quarter ended December 31, 2025) results, with operating revenue of Rs. 60 crore, up 176% year-on-year. Operating EBITDA jumped 772% YoY to Rs. 12 crore, while profit after tax grew 26% YoY to Rs. 6.8 crore. For the nine-month period, revenue rose 156% YoY to Rs. 178.5 crore, EBITDA surged 595% to Rs. 29.9 crore, and PAT grew 309% to Rs. 35.8 crore. The company highlighted progress in its defence and digital businesses, including a 400,000 sq ft precision manufacturing facility in Bengaluru (Phase I by March 2027) and a new CDSCO licence to manufacture medical device implants. Chairman Abhishek Singhania said the company is on track to emerge as a technology-led leader in defence and digital manufacturing.
Strong revenue and EBITDA growth, especially in core operations, is a positive signal for shareholders, though the relatively modest PAT growth in Q3 suggests margin or cost pressures. Expansion announcements in defence and medical devices indicate future growth potential that could support investor sentiment.